Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors. 2015

Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
Chemistry Department, Faculty of Science, Fayoum University, El-Fayoum 63551, Egypt. mgb00@fayoum.edu.eg.

The usefulness of non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by their gastrointestinal side effects. Non-selective cyclooxygenases inhibitors interfere with both COX-1 and COX-2 isozymes. Since COX-1 mediates cytoprotection of gastric mucosa, its inhibition leads to the undesirable side effects. On the other hand, COX-2 is undetectable in normal tissues and selectively induced by inflammatory stimuli. Therefore, it is strongly believed that the therapeutic benefits derive from inhibition of COX-2 only. The presence of a strong connection between reported COX-2 inhibitors and cardiac toxicity encourages medicinal chemists to explore new scaffolds. In the present study, we introduced imidazopyrazolopyridines as new potent and selective COX-2 inhibitors that lack the standard pharmacophoric binding features to hERG. Starting from our lead compound 5a, structure-based drug-design was conducted and more potent analogues were obtained with high COX-2 selectivity and almost full edema protection, in carrageenan-induced edema assay, in case of compound 5e. Increased bulkiness around imidazopyrazolopyridines by adding a substituted phenyl ring(s) afforded less active compounds.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
January 2018, Iranian journal of pharmaceutical research : IJPR,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
March 2021, Archiv der Pharmazie,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
February 2008, Bioorganic & medicinal chemistry letters,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
January 2021, Archiv der Pharmazie,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
September 2019, Bioorganic chemistry,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
May 2019, Bioorganic chemistry,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
October 2017, Archiv der Pharmazie,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
March 2007, Bioorganic & medicinal chemistry,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
January 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Mohamed G Badrey, and Hassan M Abdel-Aziz, and Sobhi M Gomha, and Mohamed M Abdalla, and Abdelrahman S Mayhoub
July 2020, Bioorganic chemistry,
Copied contents to your clipboard!